Fmoc-Thr(tBu)-OPfp

Fmoc-Thr(tBu)-OPfp is an Fmoc-protected threonine derivative bearing a tert-butyl-protected side-chain hydroxyl and an OPfp ester (pentafluorophenyl ester) at the carboxylate position, yielding a chiral amino acid intermediate with defined stereochemistry at the threonine Cα center. The molecule combines an Fmoc carbamate on the amino functionality with a bulky, acid-stable tBu ether on the side-chain oxygen, while the OPfp group provides a highly activated carboxylate for acyl transfer chemistry. The pentafluorophenyl ester's electron-withdrawing fluorinated aromatic ring enhances leaving-group ability, enabling controlled formation of amide bonds under peptide-coupling conditions. The presence of orthogonal protection elements (Fmoc versus tBu versus OPfp) supports stepwise synthesis, including selective deprotection and downstream conversion into peptide building blocks and other acylated intermediates for synthetic organic chemistry and biochemical research.

1. Peptide Synthesis

Fmoc-Thr(tBu)-OPfp is used in peptide building block preparation where the OPfp ester functions as an activated carboxylate for rapid amide bond formation with amino components. The Fmoc group provides orthogonal N-protection compatible with standard Fmoc/tBu peptide strategies, while the threonine side-chain tBu ether protects the hydroxyl from premature acylation or side reactions during coupling cycles. The chiral threonine backbone enables incorporation of stereodefined Thr residues into peptide sequences, supporting structure-activity relationship studies that depend on precise side-chain stereochemistry. The activated ester format can also support convergent fragment assembly and subsequent peptide elongation, producing protected peptide intermediates that can be carried through SPPS-compatible purification and deprotection steps.

2. Amino Acid Derivatization

Fmoc-Thr(tBu)-OPfp is applied in amino acid derivatization and acylation chemistry as a pentafluorophenyl ester that can undergo controlled conversion into amides and related carbonyl-containing derivatives. The OPfp functionality enables nucleophile-driven acyl transfer to introduce the threonine carboxyl unit into diverse substrates while maintaining the orthogonally protected side-chain hydroxyl as a tBu ether. The Fmoc-protected amine further constrains reactivity, allowing selective downstream transformations after Fmoc removal and/or tBu deprotection depending on the synthetic sequence. The resulting acylated products can serve as intermediates for peptidomimetic construction, linker synthesis, and protected amino acid chemistry workflows that require stereodefined chiral building blocks.

3. Bioconjugation Chemistry

Fmoc-Thr(tBu)-OPfp supports bioconjugation and chemical biology workflows where threonine-based linkers or acylated handles are required for controlled attachment to biomolecules. The protected threonine hydroxyl (tBu ether) helps prevent uncontrolled conjugation at the side-chain oxygen during ester-to-amide formation, while the OPfp group can be leveraged to generate amide-linked conjugates under coupling conditions. The Fmoc group can be removed to expose the amino functionality for subsequent derivatization steps, enabling sequential construction of conjugation motifs with defined functional group presentation. Downstream conjugates derived from this intermediate can be used to generate labeled peptides, biomolecule-modified probes, or scaffold fragments for studying molecular recognition and biomolecular interactions.

4. Peptidomimetics And SAR

Fmoc-Thr(tBu)-OPfp is suitable for peptidomimetic construction and structure-activity relationship studies that require threonine-derived fragments with controlled protection patterns. The combination of a stereodefined threonine core and protected side-chain hydroxyl enables incorporation of polar functionality into analogs that mimic phosphorylation-prone or hydrogen-bonding motifs while avoiding side reactions during synthesis. The activated OPfp ester format allows efficient installation of the threonine carboxyl group into non-natural scaffolds, including amide-bearing linkers and constrained analogs used in SAR mapping. The orthogonal Fmoc and tBu protection strategy supports iterative synthesis of analog libraries, where selective deprotection can reveal functional groups for further elaboration such as hydroxyl modification or subsequent coupling.

5. Process Chemistry Intermediate

Fmoc-Thr(tBu)-OPfp is relevant to process chemistry intermediate development for manufacturing peptide building blocks and activated amino acid esters with robust handling characteristics. The OPfp ester provides a chemically activated, leaving-group-enhanced carboxylate that can be converted into amide products using standard coupling reagents, aligning with scalable synthetic planning for fine chemical production. The orthogonal protection set (Fmoc carbamate and tBu ether) supports predictable deprotection logic in downstream steps, reducing cross-reactivity between amine and hydroxyl functionalities during multistep sequences. The stereodefined threonine scaffold and activated ester chemistry make it suitable for producing consistent, sequence-ready intermediates used in peptide manufacturing and industrial synthesis of protected amino acid derivatives.

1. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging

2. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

3. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma

4. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats

5. Implications of ligand-receptor binding kinetics on GLP-1R signalling